Statistics for Addition of Infliximab to Standard Acute Graft-versus-Host Disease Prophylaxis following Allogeneic Peripheral Blood Cell Transplantation
Total visits
| views | |
|---|---|
| Addition of Infliximab to Standard Acute Graft-versus-Host Disease Prophylaxis following Allogeneic Peripheral Blood Cell Transplantation | 72 |
Total visits per month
| views | |
|---|---|
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:1f7590f4-aecc-431c-b497-b741b75d288a | 33 |
| Hamadani2008Addition-CCBYNCND.pdf | 25 |
| java.util.UUID:481cc175-9a5e-4e21-b61b-a2825517b724 | 10 |
| java.util.UUID:f070fb86-446f-4862-8802-b6f9f25f33f4 | 8 |
Top country views
| views | |
|---|---|
| United States | 66 |
| Malaysia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 43 |
| Fairfield | 5 |
| Houston | 5 |
| Ann Arbor | 3 |
| White Plains | 3 |
| Cambridge | 1 |
| Indianapolis | 1 |
| Mount Laurel | 1 |
| Seremban | 1 |